1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-pyrrolopyridines are 5-HT6 receptor ligands

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 24, 2009, Pages 6935-6938

  Bernotas, Ronald C ^a   Antane, Schuyler A ^a   Lenicek, Steven E ^a   Haydar, Simon N ^a   Robichaud, Albert J ^a   Harrison, Boyd L ^a   Zhang, Guo Ming ^a   Smith, Deborah ^a   Coupet, Joseph ^a   Schechter, Lee E ^a  

^a PFIZER INC   (United States)

Author keywords

5 HT6 receptor; Agonist; Antagonist; Pyrrolo 2,3 c pyridine; Pyrrolo 3,2 b pyridine; Pyrrolo 3,2 c pyridine; Serotonin; Sulfone

Indexed keywords

1 (2 AMINOETHYL) 3 (SULFONYL) 1H PYRROLOPYRIDINE; SEROTONIN 6 ANTAGONIST; SEROTONIN 6 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG SYNTHESIS; LIGAND BINDING; STRUCTURE ACTIVITY RELATION;

HELA CELLS; HUMANS; LIGANDS; PYRIDINES; PYRROLES; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 71849116724     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.10.067     Document Type: Article

References (21)

1. Foley A.G., Murphy K.J., Hirst W.D., Gallagher H.C., Hagan J.J., Upton N., Walsh F.S., and Regan C.M. Neuropsychopharmacology 29 (2004) 93
2. Lindner M.D., Hodges D.B., Hogan J.B., Orie A.F., Corsa J.A., Barten D.M., Polson C., Robertson B.J., Guss V.L., Gillman K.W., Starrett J.E., and Gribkoff V.K. J. Pharmacol. Exp. Ther. 307 (2003) 682
3. King M.V., Sleight A.J., Woolley M.L., Topham I.A., Marsden C.A., and Fone K.C.F. Neuropharmacology 47 (2004) 195
4. Russell M.G.N., and Dias R. Curr. Top. Med. Chem. 2 (2002) 643
5. 6 receptor ligands and their biological functions, see:. Glennon R.A. J. Med. Chem. 46 (2003) 2795
6. Holenz J., Pauwels P.J., Diaz J.L., Merce R., Codony X., and Buschmann H. Drug Discovery Today 11 (2006) 283
7. Liu K.G., and Robichaud A.J. Drug Dev. Res. 70 (2009) 145
8. Tsai Y., Dukat M., Slassi A., MacLean N., Demchyshyn L., Savage J.E., Roth B.L., Hufesein S., Lee M., and Glennon R.A. Bioorg. Med. Chem. Lett. 10 (2000) 2295
9. Russell M.G.N., Baker R.J., Barden L., Beer M.S., Bristow L., Broughton H.B., Knowles M., McAllister G., Patel S., and Castro J.L. J. Med. Chem. 44 (2001) 3881
10. Cole D.C., Lennox W.J., Lombardi S., Ellingboe J.W., Bernotas R.C., Tawa G., Mazandarani H., Smith D.L., Zhang G., Coupet J., and Schechter L.E. J. Med. Chem. 48 (2005) 353
11. Bernotas R.C., Lenicek S., Antane S., Zhang G.M., Smith D., Coupet J., Harrison B., and Schechter L.E. Bioorg. Med. Chem. Lett. 14 (2004) 5499
12. Bernotas R.C., Lenicek S., Antane S., Cole D.C., Harrison B., Robichaud A., Zhang G.-M., Smith D.L., Platt B., Lin Q., Li P., Coupet J., Rosenzweig-Lipson S., Beyer C.E., and Schechter L.E. Bioorg. Med. Chem. 17 (2009) 5153
13. Makosza M., Glinka T., and Kinowski A. Tetrahedron 40 (1984) 1863
14. Wojciechowski K., and Makosza M. Synthesis (1986) 651
15. Wojciechowski K., and Makosza M. Tetrahedron Lett. 25 (1984) 4793
16. Antane S., Bernotas R., McDevitt R., Yan Y., and Li Y. Synth. Commun. 34 (2004) 2443
17. Makosza M., Chylinska B., and Mudryk B. Liebigs Ann. Chem. (1984) 8
18. 1H NMR and MS. For additional synthetic details, see: Bernotas, R. C.; Lenicek, S. E.; Antane, S. A. U.S. Patent 6,825,212.
19. Katz R.B., and Voyle M. Synthesis (1989) 314
20. Webb K.S. Tetrahedron Lett. 35 (1994) 3457
21. 6 receptor were used. The% efficacy is relative to serotonin. For detailed assay conditions, see:. Cole D.C., Stock J.R., Lennox W.J., Bernotas R.C., Ellingboe J.W., Boikess S., Coupet J., Smith D.L., Leung L., Zhang G.M., Feng X.D., Kelly M.F., Galante R., Huang P.Z., Dawson L.A., Marquis K., Rosenzweig-Lipson S., Beyer C.E., and Schechter L. J. Med. Chem. 50 (2007) 5535